{
    "clinical_study": {
        "@rank": "67254", 
        "arm_group": [
            {
                "arm_group_label": "Standard chemoradiotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Standard chemoradiotherapy (Capecitabine 825mg/m2 combined with radiotherapy )"
            }, 
            {
                "arm_group_label": "induction and gap chemotherapy", 
                "arm_group_type": "Experimental", 
                "description": "induction chemotherapy (Capecitabine 2000mg/m2 +oxaliplatine 130mg/m2) + standard chemoradiotherapy (Capecitabine 2000mg/m2 combined with radiotherapy) + gap chemotherapy (Capecitabine 2000mg/m2 + oxaliplatine 130mg/m2)"
            }
        ], 
        "brief_summary": {
            "textblock": "Although neoadjuvant chemoradiotherapy has significantly reduced the risk of local\n      recurrence in locally advanced rectal cancer, systemic failure remains a predominant issue\n      probably due to the insufficient control of systemic micro-metastasis in the neoadjuvant\n      treatment. Induction chemotherapy is one of the most studied strategies. However, the\n      efficacy of induction chemotherapy prior to neoadjuvant chemotherapy remains controversial.\n      In our previous study, induction chemotherapy, gap chemotherapy combined with neoadjuvant\n      chemoradiotherapy can improve response rate of rectal cancer patients, but the results have\n      not been confirmed in clinical trial. Whether this new kind of treatment can optimize\n      neoadjuvant therapy for locally advanced rectal cancer or not is still a big problem in\n      clinical practice. This study will focus on how to optimize neoadjuvant chemotherapy."
        }, 
        "brief_title": "Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer", 
        "completion_date": {
            "#text": "January 2023", 
            "@type": "Anticipated"
        }, 
        "condition": "Advanced Rectal Cancer", 
        "condition_browse": {
            "mesh_term": "Rectal Neoplasms"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Pathological confirmed rectal cancer\n\n          -  Clinical stage T3-4 or T any N1\n\n          -  No metastasis\n\n          -  Distance of tumor is no more than 10cm from anal verge\n\n          -  No previous radiotherapy\n\n          -  Age ranged from 18 to 70\n\n          -  Eastern Cooperative Oncology Group score system 0-1\n\n        Exclusion Criteria:\n\n          -  Clinical stage T1-2 N0\n\n          -  Distance metastasis\n\n          -  Multiple primary tumor\n\n          -  Cachexy"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "556", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02031939", 
            "org_study_id": "2013013", 
            "secondary_id": "SYSU5010Fund"
        }, 
        "intervention": [
            {
                "arm_group_label": "induction and gap chemotherapy", 
                "description": "All rectal cancer patients in this group will receive induction, gap chemotherapy(capecitabine combine with oxaliplatin) alone with standard chemoradiotherapy before surgery.", 
                "intervention_name": "Induction and gap chemotherapy (Capecitabine combine with oxaliplatin)", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Xeloda", 
                    "Eloxatin"
                ]
            }, 
            {
                "arm_group_label": [
                    "Standard chemoradiotherapy", 
                    "induction and gap chemotherapy"
                ], 
                "description": "All rectal patients in this group will receive standard chemoradiotherapy and surgical resection.", 
                "intervention_name": "standard chemoradiotherapy", 
                "intervention_type": "Radiation"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Oxaliplatin", 
                "Capecitabine"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Rectal cancer", 
            "neoadjuvant chemoradiotherapy", 
            "optimization"
        ], 
        "lastchanged_date": "February 8, 2014", 
        "location": {
            "contact": {
                "email": "luzhh@sysucc.org.cn", 
                "last_name": "Zhen-Hai Lu, Prof.", 
                "phone": "+86 20 87343584"
            }, 
            "contact_backup": {
                "email": "zhangrx@sysucc.org.cn", 
                "last_name": "Rong-Xin Zhang, M.D.", 
                "phone": "+86 20 87343456"
            }, 
            "facility": {
                "address": {
                    "city": "Guangzhou", 
                    "country": "China", 
                    "state": "Guangdong", 
                    "zip": "510060"
                }, 
                "name": "Sun Yat-Sen University Cancer Center"
            }, 
            "investigator": [
                {
                    "last_name": "Zhen-Hai Lu, Prof.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Rong-Xin Zhang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Fu-Long Wang, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Yuan-Hong Gao, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Yu-Jing Fang, PhD.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Xiao-Jun Wu, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Zhi-Zhong Pan, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Gong Chen, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Pei-Rong Ding, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Zhi-Fan Zeng, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Jun-Zhong Lin, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "Qing Liu, M.D.", 
                    "role": "Sub-Investigator"
                }, 
                {
                    "last_name": "De-Sen Wan, Prof.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "Randomized Controlled Study on Optimize Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer", 
        "overall_contact": {
            "email": "luzhh@sysucc.org.cn", 
            "last_name": "Zhen-Hai Lu, Prof.", 
            "phone": "+86 20 87343584"
        }, 
        "overall_contact_backup": {
            "email": "zhangrx@sysucc.org.cn", 
            "last_name": "Rong-Xin Zhang, M.D.", 
            "phone": "+86 20 87343456"
        }, 
        "overall_official": {
            "affiliation": "Sun Yat-sen University", 
            "last_name": "Zhen-Hai Lu, Prof.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Sun Yat-Sen University Cancer Center Ethic Commitee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "January 2018", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "overall survival", 
            "safety_issue": "Yes", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02031939"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-sen University", 
            "investigator_full_name": "Zhen-Hai Lu", 
            "investigator_title": "Pofessor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "disease free survival", 
                "safety_issue": "Yes", 
                "time_frame": "3 years"
            }, 
            {
                "measure": "Disease free survival", 
                "safety_issue": "No", 
                "time_frame": "5 years"
            }, 
            {
                "measure": "Respond rate", 
                "safety_issue": "Yes", 
                "time_frame": "One week after surgery"
            }
        ], 
        "source": "Sun Yat-sen University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Sun Yat-sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2014"
    }
}